FI964833A - Pantropiska neurotrofiska faktorer - Google Patents

Pantropiska neurotrofiska faktorer Download PDF

Info

Publication number
FI964833A
FI964833A FI964833A FI964833A FI964833A FI 964833 A FI964833 A FI 964833A FI 964833 A FI964833 A FI 964833A FI 964833 A FI964833 A FI 964833A FI 964833 A FI964833 A FI 964833A
Authority
FI
Finland
Prior art keywords
pantropic
neurotrophic factors
pantropic neurotrophic
neurotrophic
factors
Prior art date
Application number
FI964833A
Other languages
English (en)
Finnish (fi)
Other versions
FI964833A0 (sv
FI120237B (sv
Inventor
Roman Urfer
Leonard G Presta
John Winslow
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22962278&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI964833(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of FI964833A0 publication Critical patent/FI964833A0/sv
Publication of FI964833A publication Critical patent/FI964833A/sv
Application granted granted Critical
Publication of FI120237B publication Critical patent/FI120237B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/48—Nerve growth factor [NGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI964833A 1994-06-03 1996-12-03 Pantropisk neurotrofin-polypeptid FI120237B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US25393794A 1994-06-03 1994-06-03
US25393794 1994-06-03
US9506918 1995-06-01
PCT/US1995/006918 WO1995033829A1 (en) 1994-06-03 1995-06-01 Pantropic neurotrophic factors

Publications (3)

Publication Number Publication Date
FI964833A0 FI964833A0 (sv) 1996-12-03
FI964833A true FI964833A (sv) 1996-12-03
FI120237B FI120237B (sv) 2009-08-14

Family

ID=22962278

Family Applications (1)

Application Number Title Priority Date Filing Date
FI964833A FI120237B (sv) 1994-06-03 1996-12-03 Pantropisk neurotrofin-polypeptid

Country Status (17)

Country Link
US (6) US5728803A (sv)
EP (1) EP0763107B1 (sv)
JP (1) JPH10501138A (sv)
CN (1) CN1159439C (sv)
AT (1) ATE280825T1 (sv)
AU (1) AU695144B2 (sv)
BR (1) BR9508019B1 (sv)
CA (1) CA2191064C (sv)
DE (1) DE69533698T2 (sv)
ES (1) ES2231786T3 (sv)
FI (1) FI120237B (sv)
IL (1) IL113983A0 (sv)
MX (1) MX9605971A (sv)
NO (1) NO317938B1 (sv)
NZ (1) NZ287762A (sv)
PT (1) PT763107E (sv)
WO (1) WO1995033829A1 (sv)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5728803A (en) * 1994-06-03 1998-03-17 Genentech, Inc. Pantropic neurotrophic factors
DE19637718A1 (de) 1996-04-01 1997-10-02 Boehringer Mannheim Gmbh Rekombinante inaktive Core-Streptavidin Mutanten
BR9713055A (pt) * 1996-11-15 2000-04-04 Genentech Inc Processo para isolar uma neurotrofina humana recombinante, composição de neurotrofina e processo para purificar uma neurotrofina
US6391571B1 (en) 1997-04-01 2002-05-21 Roche Diagnostics Gmbh Recombinant inactive avidin mutants
WO1998049308A1 (en) * 1997-04-25 1998-11-05 Genentech, Inc. Ngf variants
US6365373B2 (en) 1997-04-25 2002-04-02 Genentech, Inc. Nucleic acids encoding NGF variants
US7452863B1 (en) 1997-04-29 2008-11-18 Genentech, Inc. NGF variants
US6113947A (en) * 1997-06-13 2000-09-05 Genentech, Inc. Controlled release microencapsulated NGF formulation
US6663899B2 (en) 1997-06-13 2003-12-16 Genentech, Inc. Controlled release microencapsulated NGF formulation
US20040120891A1 (en) * 1998-12-21 2004-06-24 Craig Hill Compounds for intracellular delivery of therapeutic moieties to nerve cells
US6652864B1 (en) * 1998-12-21 2003-11-25 Asilomar Pharmaceuticals, Inc. Compounds for intracellular delivery of therapeutic moieties to nerve cells
GB0024550D0 (sv) 2000-10-06 2000-11-22 Oxford Biomedica Ltd
US7727527B2 (en) * 2001-05-30 2010-06-01 Genentech, Inc. Anti-NGF antibodies for the therapeutic treatments
US20040096089A1 (en) * 2002-08-16 2004-05-20 David Borsook Non-invasive functional imaging of peripheral nervous system activation in humans and animals
AU2003287930A1 (en) 2002-12-20 2004-07-14 Neuronicon Aps Modulation of activity of neurotrophins
US20080260722A1 (en) * 2004-12-30 2008-10-23 The Johns Hopkins University Johns Hopkins Technology Transfer Method for High Efficiency Survival/Proliferation of Human Embyonic Stem Cells and Human Embryo Survival in Culture
ES2624180T3 (es) * 2006-12-21 2017-07-13 H. Lundbeck A/S Modulación de la actividad de proneurotrofinas
WO2009062149A1 (en) * 2007-11-08 2009-05-14 Creighton University Methods for maintaining inner ear neurons
US8447409B2 (en) * 2008-10-15 2013-05-21 Cochlear Limited Electroneural interface for a medical implant
US8259461B2 (en) * 2008-11-25 2012-09-04 Micron Technology, Inc. Apparatus for bypassing faulty connections
US9539324B2 (en) 2010-12-01 2017-01-10 Alderbio Holdings, Llc Methods of preventing inflammation and treating pain using anti-NGF compositions
EP3434691A1 (en) 2010-12-01 2019-01-30 AlderBio Holdings LLC Anti-ngf compositions and use thereof
US11214610B2 (en) 2010-12-01 2022-01-04 H. Lundbeck A/S High-purity production of multi-subunit proteins such as antibodies in transformed microbes such as Pichia pastoris
US9884909B2 (en) 2010-12-01 2018-02-06 Alderbio Holdings Llc Anti-NGF compositions and use thereof
US9078878B2 (en) 2010-12-01 2015-07-14 Alderbio Holdings Llc Anti-NGF antibodies that selectively inhibit the association of NGF with TrkA, without affecting the association of NGF with p75
US9067988B2 (en) 2010-12-01 2015-06-30 Alderbio Holdings Llc Methods of preventing or treating pain using anti-NGF antibodies
EP4292649A3 (en) * 2016-03-18 2024-02-21 Staidson(Beijing) Biopharmaceuticals Co., Ltd. Fusion protein comprising nerve growth factor and preparation method and use thereof
CN107286233B (zh) * 2016-04-13 2020-11-06 舒泰神（北京）生物制药股份有限公司 低痛神经生长因子突变体
CN110183536B (zh) * 2018-02-22 2021-01-15 中国科学院遗传与发育生物学研究所 一种复合支架材料及其应用
WO2020018700A1 (en) 2018-07-18 2020-01-23 Manzanita Pharmaceuticals, Inc. Conjugates for delivering an anti-cancer agent to nerve cells, methods of use and methods of making thereof
CN110812532A (zh) * 2019-08-20 2020-02-21 中山大学 一种靶向促进皮质脊髓束连接以修复脊髓损伤的组织工程支架的构建方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169764A (en) * 1990-08-08 1992-12-08 Regeneron Pharmaceuticals, Inc. Multitrophic and multifunctional chimeric neurotrophic factors, and nucleic acids and plasmids encoding the chimeras
US5488099A (en) * 1992-03-06 1996-01-30 Persson, Deceased; Hakan B. Multifunctional chimeric neurotrophic factors
US5349055A (en) * 1992-03-06 1994-09-20 Persson Hakan B Nerve growth factor having altered receptor binding specificities
WO1993025684A1 (en) * 1992-06-12 1993-12-23 Regeneron Pharmaceuticals, Inc. Therapeutic and diagnostic methods based on neurotrophin-4 expression
US5753225A (en) 1993-12-03 1998-05-19 The Regents Of The University Of California Antibodies that mimic actions of neurotrophins
US5939534A (en) * 1993-12-29 1999-08-17 Sumitomo Pharmaceuticals Company, Limited Factors mutated in the D1 cap region
US7144983B1 (en) * 1997-02-03 2006-12-05 Genentech, Inc. Pantropic neurotrophic factors
US5728803A (en) * 1994-06-03 1998-03-17 Genentech, Inc. Pantropic neurotrophic factors

Also Published As

Publication number Publication date
US7935671B2 (en) 2011-05-03
BR9508019A (pt) 1997-09-09
US6503728B1 (en) 2003-01-07
CN1153528A (zh) 1997-07-02
BR9508019B1 (pt) 2012-06-12
ES2231786T3 (es) 2005-05-16
NO965123D0 (no) 1996-12-02
AU2659295A (en) 1996-01-04
US20060270838A1 (en) 2006-11-30
US7528233B2 (en) 2009-05-05
DE69533698D1 (de) 2004-12-02
ATE280825T1 (de) 2004-11-15
US6333310B1 (en) 2001-12-25
FI964833A0 (sv) 1996-12-03
NO317938B1 (no) 2005-01-10
IL113983A0 (en) 1995-10-31
PT763107E (pt) 2005-02-28
CA2191064C (en) 2009-11-03
DE69533698T2 (de) 2006-02-09
NZ287762A (en) 1999-01-28
WO1995033829A1 (en) 1995-12-14
EP0763107B1 (en) 2004-10-27
EP0763107A1 (en) 1997-03-19
CA2191064A1 (en) 1995-12-14
JPH10501138A (ja) 1998-02-03
FI120237B (sv) 2009-08-14
US5728803A (en) 1998-03-17
US5981480A (en) 1999-11-09
MX9605971A (es) 1997-12-31
AU695144B2 (en) 1998-08-06
NO965123L (no) 1997-02-03
CN1159439C (zh) 2004-07-28
US20100184656A1 (en) 2010-07-22

Similar Documents

Publication Publication Date Title
FI964833A0 (sv) Pantropiska neurotrofiska faktorer
DE69421100D1 (de) Aufbereitung von schweren endprodukten des fischer-tropsch-verfahrens
MXPA02001911A (es) Anticuerpos ctla-4 humanos y sus usos.
DE69331484D1 (de) N-Acetylglucosaminyl-Transferase, dafür kodierendes Gen, entsprechende Vektoren und transformierte Wirte und Herstellungsverfahren dafür
PT915697E (pt) Anticonvulsionantes derivados do sulfamato uteis no tratamento da obesidade
NO980255D0 (no) Antiparasittiske marcfortiner og paraherkvamider
DE59406123D1 (de) Haarbehandlungsmittel
MY115977A (en) Synthetic excitatory amino acids
EP0820467A4 (en) METHODS OF TREATING EYE DISORDERS
FI961083A (sv) Rekombinanta IL-4antikroppar som är användbara vid behandling av IL4-förmedlade störningstillstånd
WO2002004677A8 (en) Methods for diagnosis and treatment of psychiatric disorders
FI974640A (sv) 1,6-disubstituerade isokromaner för behandling av migrän
CA2217551A1 (en) Photoactivated hypericin and the use thereof
ITMI951446A0 (it) Procedimento per la produzione di uretani aromatici
ITRM930502A0 (it) Procedimento per la produzione di r amminocarnitina e s amminocarnitina.
DE59504918D1 (de) Direktziehendes haarfärbemittel
IT1292040B1 (it) Processo per la preparazione di prodotti politriazinici contenenti gruppi 2,2,6,6-tetrametil-4-piperidile
ATE356212T1 (de) O-fukosyltransferase
DE69435058D1 (de) Vektor zur vielfachklonierung, expressionsvektor und herstellung von fremdprotein mit expressionsvektor
ITPD960038V0 (it) Associazione di porfirina cationica e sorgente luminosa coerente o noncoerente per il trattamento di infezioni microbiche dell'endodonto e del periimpianto
AU1278700A (en) Novel therapeutic use of 1,6-dimethyl-8beta-hydroxymethyl-10alpha-methoxyergoline
ITMI931527A0 (it) Procedimento e manufatto semilavorato per la produzione di calze- mutande
ITTO940003A0 (it) Procedimento per la formazione di conduttori ctc e testa traspositriceper l'attuazione del procedimento.
DK0763107T3 (da) Pantropiske neurotrofiske faktorer
IT240450Y1 (it) Astuccio per prodotti cosmetici in genere,con possibilita' disostituzione della vaschetta portacosmetico

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 120237

Country of ref document: FI

MA Patent expired